Menu
Menu
Building a leading retinal therapeutics franchise
Our high-value, near-term pipeline uses our innovative technology to create differentiated product candidates with the potential to transform the treatment paradigm for retinal disorders.
Building a leading retinal therapeutics franchise
Our high-value, near-term pipeline uses our innovative technology to create differentiated product candidates with the potential to transform the treatment paradigm for retinal disorders.
The Pipeline
We are developing a pipeline of highly differentiated product candidates that incorporates new capabilities to transform the treatment of high-prevalence ophthalmology diseases
Product
Indications
Preclinical IND Phase 2/2b
The Pipeline
We are developing a pipeline of highly differentiated product candidates that incorporates new capabilities to transform the treatment of high-prevalence ophthalmology diseases
Product
Indications
Preclinical IND Phase 2/2b
General
+44 (0)1865 636200
inquiries@oxular.com
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Limited company registered in
England and Wales
Registration No. 09331313
VAT No. GB 244 5883 81
Copyright Oxular Limited
Media
+1 617 895 9511
monique@thrustsc.com
Monique Allaire
Thrust
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting